Carmell(CTCX.US) Director Buys US$4,409.2 in Common Stock
Carmell(CTCX.US) Officer Buys US$1,100 in Common Stock
Carmell(CTCX.US) 10% Shareholder Buys US$10,577.97 in Common Stock
Carmell(CTCX.US) Officer Buys US$1,008.75 in Common Stock
Carmell(CTCX.US) 10% Shareholder Buys US$10,240.99 in Common Stock
10-Q: Quarterly report
Express News | Carmell Files For Resale Of Up To 1.3M Common Shares By The Selling Stockholders
Express News | Carmell Corp Files for Resale of up to 1.3 Mln Common Shares by the Selling Stockholders - SEC Filing
Why Nucor Shares Are Trading Lower? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Express News | Carmell Announces Successful Closing of $3.0 Million Private Placement
Express News | Carmell Shares Are Trading Lower After the Company Announced a $3 Million Private Placement of About ~1,333,333 Shares of Its Common Stock at a Price O $2.25 per Common Share
12 Health Care Stocks Moving In Thursday's Intraday Session
Carmell Announces $3.0 Million Private Placement
Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction
Exchange-Traded Funds, Equity Futures Higher Pre-Bell Thursday as Fed Maintains Rate Cut Outlook
Carmell Sells Axolotl Biologix Unit -- Shares Jump Premarket
Carmell Looks to Sell Axolotl Biologix
Express News | Carmell To Sell Its Axolotl Biologix Subsidiary For 3,845,337 Shares Of Carmell Common Stock, 4,243 Shares Of Carmell Preferred Stock And Notes Payable To The Initial Sellers In The Aggregate Amount Of $8M
Carmell Sharpens Aesthetics Focus With Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary
Carmell to Host Investor Webinar, "Unveiling the Secretome: On the Eve of Product Launch" Featuring Key Opinion Leaders in the Medical Aesthetics Field
No Data